- Home
- TLSI vs PEBK Comparison
TLSI vs PEBK Comparison
Compare TLSI & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- PEBK
- Stock Information
- Founded
- TLSI 2010
- PEBK 1912
- Country
- TLSI United States
- PEBK United States
- Employees
- TLSI N/A
- PEBK N/A
- Industry
- TLSI Medical Specialities
- PEBK Major Banks
- Sector
- TLSI Health Care
- PEBK Finance
- Exchange
- TLSI Nasdaq
- PEBK Nasdaq
- Market Cap
- TLSI 150.3M
- PEBK 169.6M
- IPO Year
- TLSI N/A
- PEBK N/A
- Fundamental
- Price
- TLSI $4.93
- PEBK $29.18
- Analyst Decision
- TLSI Strong Buy
- PEBK
- Analyst Count
- TLSI 6
- PEBK 0
- Target Price
- TLSI $11.75
- PEBK N/A
- AVG Volume (30 Days)
- TLSI 33.1K
- PEBK 12.8K
- Earning Date
- TLSI 11-14-2024
- PEBK 01-28-2025
- Dividend Yield
- TLSI N/A
- PEBK 2.60%
- EPS Growth
- TLSI N/A
- PEBK 1.99
- EPS
- TLSI N/A
- PEBK 2.95
- Revenue
- TLSI $26,891,000.00
- PEBK $79,995,000.00
- Revenue This Year
- TLSI $60.96
- PEBK N/A
- Revenue Next Year
- TLSI $53.65
- PEBK N/A
- P/E Ratio
- TLSI N/A
- PEBK $9.90
- Revenue Growth
- TLSI 67.90
- PEBK 3.47
- 52 Week Low
- TLSI $3.50
- PEBK $23.74
- 52 Week High
- TLSI $10.42
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- TLSI 56.22
- PEBK 41.08
- Support Level
- TLSI $4.53
- PEBK $28.00
- Resistance Level
- TLSI $4.92
- PEBK $31.08
- Average True Range (ATR)
- TLSI 0.29
- PEBK 0.93
- MACD
- TLSI -0.02
- PEBK -0.20
- Stochastic Oscillator
- TLSI 50.63
- PEBK 28.03
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.